Komori
Results2206Ezaki Glico Co.,Ltd.Food

Consolidated Financial Results for the Nine Months Ended December 2026 (Japanese GAAP)

For January–September 2026, revenue increased 6.1% year on year, while operating profit decreased 8.6%. Ordinary profit and net income increased, and the full-year earnings forecast and annual dividend forecast were left unchanged.

Worth reading
45Recurring
Scored from 5 of 6 sections
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
-774
¥ millions (year-on-year change in operating income)
Wording
Conditional
How definitive the wording is.

Results for this period

Third quarter1 January 2026 to 30 September 2026ConsolidatedJapanese GAAP
Net Sales281,008¥ millionYear on year +6.1%Progress 72.1%
Operating profit8,246¥ millionYear on year -8.6%Progress 68.7%
Ordinary income11,056¥ millionYear on year +1.7%Progress 79.0%
Net income attributable to owners of the parent7,719¥ millionYear on year +6.2%Progress 85.8%

The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.

Net income per share¥124.96
Financial position at period-end
Total assets372,995¥ million
of which net assets 258,218 ¥ millionEquity ratio 69.0%vs. prior year-end -1.5pt

塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.

Segment revenueHealth and Food Business ¥35,728 million (YoY -3.3%), Dairy Business ¥50,661 million (YoY +0.7%), Nutritional Confectionery Business ¥44,555 million (YoY +0.7%), Food Ingredients Business ¥9,766 million (YoY -1.6%), Domestic Other Businesses ¥58,667 million (YoY +0.3%), Overseas Business ¥81,628 million (YoY +25.9%)
Segment profitHealth and Food Business ¥-829 million, Dairy Business ¥-5,030 million, Nutritional Confectionery Business ¥1,088 million (YoY -52.2%), Food Ingredients Business ¥1,853 million (YoY +10.9%), Domestic Other Businesses ¥521 million (YoY -38.0%), Overseas Business ¥10,527 million (YoY +45.5%)
Regional sales2,135 Millions of yuan (YoY +31.5%), 102 USD million (YoY +5.0%), 67 USD million (YoY -12.9%)
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥390,000 million (YoY +7.9%)
Operating profit¥12,000 million (YoY +37.4%)
Ordinary income¥14,000 million (YoY +20.2%)
Net income¥9,000 million (YoY +78.7%)
Revision to Earnings ForecastNo change
Annual Dividend Forecast95 Yen → 95 Yen(0.0%)
Factors Behind Changes in Business Performance

Profit impact from changes in revenue: ¥7,041 million; profit impact from changes in raw material prices: △¥6,455 million; profit impact from other changes in costs: ¥3,315 million; profit impact from changes in freight and storage cost ratios: ¥1,613 million; profit impact from changes in sales promotion and advertising expenses: △¥2,344 million; profit impact from changes in general and administrative expenses: △¥3,945 million.

Disclosure regarding the going concern assumption

No applicable matters.

Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidation0 additions (company name: —), 0 exclusions (company name: —)
Impairment lossNot applicable (impairment losses on fixed assets by reporting segment)
Depreciation and amortization¥14,404 million
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingNo ( 대상자: Not disclosed)
Issued Shares at Period-End68,468,569
Treasury Shares at Period-End9,021,516
Results for this period
ItemDetails
Fiscal Period ClassificationThird quarter
Accounting standardsJapanese GAAP
Consolidated / non-consolidatedConsolidated
Period Covered1 January 2026 to 30 September 2026
Net Sales¥281,008 million (YoY +6.1%)
Operating profit¥8,246 million (YoY -8.6%)
Ordinary income¥11,056 million (YoY +1.7%)
Profit attributable to owners of the parent¥7,719 million (YoY +6.2%)
Net income per share¥124.96
Equity ratioEnd of the current fiscal period 69 / End of previous period 70.5
Total assets¥372,995 million
Net assets¥258,218 million
Full-year earnings forecastNet Sales ¥390,000 million (YoY +7.9%) / Operating profit ¥12,000 million (YoY +37.4%) / Ordinary income ¥14,000 million (YoY +20.2%) / Net income ¥9,000 million (YoY +78.7%)
Revision to Earnings ForecastNo change
Annual Dividend Forecast95 Yen → 95 Yen(0.0%)
Segment revenueHealth and Food Business ¥35,728 million (YoY -3.3%), Dairy Business ¥50,661 million (YoY +0.7%), Nutritional Confectionery Business ¥44,555 million (YoY +0.7%), Food Ingredients Business ¥9,766 million (YoY -1.6%), Domestic Other Businesses ¥58,667 million (YoY +0.3%), Overseas Business ¥81,628 million (YoY +25.9%)
Segment profitHealth and Food Business ¥-829 million, Dairy Business ¥-5,030 million, Nutritional Confectionery Business ¥1,088 million (YoY -52.2%), Food Ingredients Business ¥1,853 million (YoY +10.9%), Domestic Other Businesses ¥521 million (YoY -38.0%), Overseas Business ¥10,527 million (YoY +45.5%)
Regional sales2,135 Millions of yuan (YoY +31.5%), 102 USD million (YoY +5.0%), 67 USD million (YoY -12.9%)
Depreciation and amortization¥14,404 million
Impairment lossNot applicable (impairment losses on fixed assets by reporting segment)
Disclosure regarding the going concern assumptionNo applicable matters.
Change in accounting policyChanges due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No
Changes in the scope of consolidation0 additions (company name: —), 0 exclusions (company name: —)
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingNo ( 대상자: Not disclosed)
Issued Shares at Period-End68,468,569
Treasury Shares at Period-End9,021,516
Factors Behind Changes in Business PerformanceProfit impact from changes in revenue: ¥7,041 million; profit impact from changes in raw material prices: △¥6,455 million; profit impact from other changes in costs: ¥3,315 million; profit impact from changes in freight and storage cost ratios: ¥1,613 million; profit impact from changes in sales promotion and advertising expenses: △¥2,344 million; profit impact from changes in general and administrative expenses: △¥3,945 million.
Items this document does not state (10)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodPayout ratioShareholder Return PolicyOrders received and order backlogBreakdown of extraordinary income (loss)Material subsequent events

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Revenue increased on higher sales in the dairy and overseas businesses, among others. Operating profit declined because selling, general and administrative expenses increased by ¥6,049 million, mainly due to higher sales promotion expenses, salaries and allowances, despite a ¥5,275 million increase in gross profit. Ordinary profit increased due to foreign exchange gains and other factors.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Consolidated Financial Results for the Nine Months Ended December 2026 (Japanese GAAP) | Ezaki Glico Co.,Ltd. (2206) timely disclosure | Komori